Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
UBS
Cantor Fitzgerald
AstraZeneca
Mallinckrodt

Generated: June 26, 2019

DrugPatentWatch Database Preview

Litigation Details for Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)

Docket ➤ Try a Free Trial Date Filed 2015-09-08
Court District Court, D. Delaware Date Terminated
Cause 35:145 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties CIPLA LTD.; MEDA PHARMACEUTICALS INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 4,005,063; 4,335,121; 4,992,474; 5,164,194; 5,889,015; 5,972,920; 6,759,398; 7,629,335; 8,071,073; 8,163,723; 8,168,620; 9,259,428
Attorneys Andrew Colin Mayo; John G. Day; John W. Shaw; Karen Elizabeth Keller; Steven J. Balick
Link to Docket External link to docket

Details for Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-11-11 101 Exhibit A 4:59-5:4; 5:63-6:7; 6:59-7:3; 7:30-61. ’428 Patent (MEDA_TEVA… The ’620, 723, and ’428 patents arise from the same patent family and share substantially similar… ’723, and ’428 patents contain many of the same references. For citations to patents, the parties incorporate… MEDA_TEVA_00000733 (Non-Patent U.S. Patent No. 5,889,015 (see, e.g., Col. … MEDA_TEVA_00001353 (Non-Patent U.S. Patent No. 8,071,073 (see, e.g., Col. External link to document
2016-11-14 104 Correction ("CoC") for U.S. Patent No. 9,259,428 ('" 428 patent") into this case. (D.I…inadvertent typographical errors" in the '428 patent. (D.I. 62 at 1) "On May 3, 2016, the PTO issued…requested Certificate of Correction for the '428 patent." (Id.) Plaintiffs explain that thereafter…indefiniteness arguments regarding claim 28 of '_428 patent, arguments that would be affected by introduction…litigating the uncorrected version of the '428 patent. (See D.I. 65 at 5) (discussing litigation that External link to document
2016-12-07 113 of U.S. Patent Nos. 8,163,723; 8,168,620; and 9,259,428. With respect to the '428 patent, the PTO…construe claims 28-30 of the '428 patent, which, in the uncorrected patent, contain a typographical error…addressing construction of claims 28-30 of the '428 patent, within one week of the date of this order. Signed…additional exhibits are documents from the '428 patent's prosecution history, including a listing …in the,context of claims 28-30 of the '428 patent. 3. D~fendant opposes Plaintiffs External link to document
2016-03-18 28 Initial Infringement Contentions for U.S. Patent Nos. 8,163,723, 8,168,620, and 9,259,428 filed by Cipla…8 September 2015 1:15-cv-00785 830 Patent None District Court, D. Delaware External link to document
2015-09-08 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,723; 8,168,620;. (sar) …8 September 2015 1:15-cv-00785 830 Patent None District Court, D. Delaware External link to document
2016-09-02 56 Plaintiff Meda Pharmaceuticals Inc.’s own U.S. Patent No. 8,071,073, titled “Compositions comprising Azelastine…above, Plaintiffs’ own U.S. Patent No. 8,071,073, titled “Compositions comprising Azelastine and Methods of…Pharmaceuticals Inc.’s own contemporaneous U.S. Patent No. 8,071,073, which also relates to azelastine nasal …three patents, U.S. Patent Nos. 8,168,620 (“the ’620 patent”) (Ex. 2), 8,163,723 (“the ’723 patent”) (Ex… ’723 patent at Claim 12; ’620 patent at Claim 5; ’428 patent at Claim 3. 10 See ’723 patent, col. External link to document
2016-09-02 60 # 8 Ex. 8 WO 9715298.pdf, # 9 Ex. 9 U.S. Patent No. 5,164,194.pdf, # 10 Ex. 10 GB 2,079,755.pdf, # 11 ….pdf, # 2 Ex. 2 '620 Patent.pdf, # 3 Ex. 3 '723 Patent.pdf, # 4 Ex. 4 '428 Patent.pdf, # 5 Ex. 5 Miller-Keane…8 September 2015 1:15-cv-00785 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Citi
Medtronic
QuintilesIMS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.